Gene research could lead to new heart drugs
Scientists from Rigshospitalet and University of Copenhagen have discovered a gene variant that could play a key role in the future treatments of cardiovascular disease.
by Viktor Brandt Kærgaard
Danish scientists have shown that a particular gene variant lowers the risk of arteriosclerosis by 41 per cent, making the variant an obvious target for future drugs for cardiovascular disease treatment. People with the gene variant, apolipoprotein C3, have a significantly lower level of normal blood lipids than people without this gene variation.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Pig parasite shows promise in immune disease
For abonnenter
Research paves way for more effective diabetes care
For abonnenter
HIV can 'cut and paste' in the human genome
For abonnenter
